Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Sara A. Hurvitz
Based on 58 articles published since 2009
(Why 58 articles?)
||||
Expertise Level
The expertise of Sara A. Hurvitz ranks in the
  • Top 0.035%
  • ... of 265,285 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 58 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Hurvitz, S   ·   Hurvitz, Sara   ·   Hurvitz, S A   ·   Hurvitz, Sara A
Work Locations
Details
Most likely:    UCLA   Contact    
2019
  • Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, 2336 Santa Monica, Suite 304, Santa Monica, Los Angeles, CA, 90404, USA. · Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, 2336 Santa Monica, Suite 304, Santa Monica, Los Angeles, CA, 90404, USA. · Pubmed 31254268
  • From Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine (S.-A.I.), the Yonsei Cancer Center, Yonsei University Health System (J.S.), and the Asan Medical Center, University of Ulsan College of Medicine (K.-H.J.), Seoul, and the Center for Breast Cancer, National Cancer Center, Gyeonggi-do (K.-S.L.) - all in South Korea · National Taiwan University Hospital, Taipei, Taiwan (Y.-S.L.) · Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston (A.B.) · the Breast Center, Department of Obstetrics and Gynecology, Ludwig-Maximilians-University Munich, Munich, Germany (N.H.) · the Division of Medical Senology, Istituto Europeo di Oncologia, Milan (M.C.) · Hospital de Caridade de Ijuí, CACON, Ijuí, Brazil (F.F.) · the Organisation for Oncology and Translational Research, Hong Kong (L.C.) · Centro Oncológico Estatal, Instituto de Seguridad Social del Estado de México y Municipios, Toluca, Mexico (S.C.-G.) · Institut Català d'Oncologia, Hospital de Sant Joan Despí Moisès Broggi, Barcelona (R.V.-V.) · Novartis Pharmaceuticals, East Hanover, NJ (A.C., K.R.-L., T.T.) · Novartis, Basel, Switzerland (G.H., I.G.) · the UCLA Jonsson Comprehensive Cancer Center, Los Angeles (S.H.) · and the University of Texas M.D. Anderson Cancer Center, Houston (D.T.). · Pubmed 31166679
  • David Geffen School of Medicine at University of California, Los Angeles, CA 90095, USA. Electronic address: · Pubmed 31178153
  • Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Santa Monica, CA 90404, USA. Electronic address: · Pubmed 30739744
2018
  • University of California, Los Angeles, 10945 Le Conte Avenue PVUB 3360, Los Angeles, CA, 90095, USA. Electronic address: · Pfizer Inc., 525 Market Street, 36th Floor, San Francisco, CA, 94105, USA. Electronic address: · The Royal Marsden Hospital-The Royal Marsden NHS Foundation Trust, Fulham Road, Chelsea, London, SW3 6JJ, UK. Electronic address: · Stanford University School of Medicine, 900 Blake Wilbur Drive, 1st Floor, Palo Alto, CA, 94304, USA. Electronic address: · University of California San Francisco Comprehensive Cancer Center, 1600 Divisadero Street, 3rd Floor, San Francisco, CA, 94115, USA. Electronic address: · Centre Oscar Lambret, 3 Rue Frédéric Combemale, 59000, Lille, France. Electronic address: · Klinikum Rechts der Isar, Technische Universität München, Ismaningerstrasse 22, 81675, Munich, Germany. Electronic address: · Universitäts-Frauenklinik Calwerstr. 7, 72076, Tübingen, Germany; Eberhard Karls University, Geschwister-Scholl-Platz, 72074, Tübingen, Germany. Electronic address: · Banner MD Anderson Cancer Center, 2946 E Banner Gateway Dr, Gilbert, AZ, 85234, USA. Electronic address: · Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology, CELLEX CENTER, C/ Natzaret, 115-117, 08035, Barcelona, Spain. Electronic address: · University Hospital Erlangen, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Universitätsstraße 21-23, 91054 Erlangen Erlangen, Germany. Electronic address: · Pfizer Inc., 525 Market Street, 36th Floor, San Francisco, CA, 94105, USA. Electronic address: · Pfizer Inc., 525 Market Street, 36th Floor, San Francisco, CA, 94105, USA. Electronic address: · Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA. Electronic address: · The NIHR Manchester Clinical Research Facility at The Christie & Division of Cancer Sciences University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. Electronic address: · Pubmed 30359909
  • Centre René Gauducheau, Institut de Cancérologie de L'Ouest, Saint Herblain, France. Electronic address: · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. · Department of Breast Oncology, Aichi Cancer Center, Nagoya, Japan. · Division of Medical Oncology, Ottawa Hospital Research Institute, Ottawa, Canada. · Breast Oncology Center, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. · Medical Oncology Clinic, Institut Jules Bordet, Brussels, Belgium. · Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Oncology Center, Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology (MCMCC), Warsaw, Poland. · Macerata Hospital, Macerata, Italy. · Department of Surgery, Taipei-Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan. · UCLA Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, USA. · Department of Surgery and Breast Oncology, National Hospital Organization Osaka National Hospital, Osaka, Japan. · Institute of Oncology, Ramón y Cajal University Hospital, Madrid, Spain; Breast Cancer Research Program, Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Breast Cancer Department, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Vanderbilt-Ingram Cancer Center, Department of Medicine, Vanderbilt University, Nashville, USA. · Department of Breast Cancer, Beijing 307 Hospital of PLA, Beijing, China. · Medical Center, University Hospital Schleswig-Holstein, Kiel, Germany. · Novartis Pharma S.A.S., Paris, France. · Novartis Institutes for BioMedical Research, Cambridge, USA. · Novartis Pharmaceuticals Corporation, East Hanover, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 30241001
  • CHU Sart Tilman Liege and Liege University, Liege, Belgium. · Royal Melbourne Hospital, Victoria, Australia. · Jonsson Comprehensive Cancer Center, University of California, Los Angeles. · Sarah Cannon Research Institute, Nashville, Tennessee. · Tennessee Oncology, PLLC, Nashville, Tennessee. · Russian Cancer Research Center, Moscow, Russia. · Copenhagen University Hospital, Copenhagen, Denmark. · Rainier Hematology-Oncology, Northwest Medical Specialties, Tacoma, Washington. · Cerrahpaşa School of Medicine, Istanbul University, Istanbul, Turkey. · Uzsoki Teaching Hospital, Budapest, Hungary. · Institute of Clinical Research, Odense University Hospital, University of Southern Denmark, Odense, Denmark. · Novartis Pharmaceuticals Corporation, East Hanover, New Jersey. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharma SAS, Paris, France. · Pubmed 29862411
  • The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Seoul National University Hospital, Cancer Research Institute, and Seoul National University College of Medicine, Seoul, South Korea. · Division of Medical Senology, Istituto Europeo di Oncologia, Milan, Italy. · Hospital de Caridade de Ijuí, Cacon, Ijuí, Brazil. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. · Breast Center, Department of Obstetrics and Gynaecology, University of Munich, Munich, Germany. · UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Organisation for Oncology and Translational Research, Hong Kong Special Administrative Region, China. · Yonsei Cancer Center, Yonsei University Health System, Seoul, South Korea. · Research Institute and Hospital, National Cancer Center, Goyang, South Korea. · Centro Oncológico Estatal, Instituto de Seguridad Social del Estado de México y Municipios, Toluca, Mexico. · Institut Català d'Oncologia, Hospital Moisès Broggi, Barcelona, Spain. · Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · HCG Curie Centre of Oncology and Kidwai Memorial Institute of Oncology, Bangalore, India. · University of Ottawa, Ottawa, ON, Canada. · Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Breast Unit, Kliniken Essen-Mitte, Essen, Germany. · American University of Beirut Medical Center, Beirut, Lebanon. · Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan. · Novartis, East Hanover, NJ, USA. · Novartis, Basel, Switzerland. · National Taiwan University Hospital, Taipei, Taiwan. Electronic address: · Pubmed 29804902
  • David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. Electronic address: · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CiberOnc, GEICAM, Madrid, Spain. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, Korea. · National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. · Breast Center, University of Munich (LMU), Munich, Germany. · Moscow City Oncology Hospital 62, Moscow, Russia. · Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Centre René Gauducheau, St Herblain cedex, France. · McGill University, Sir Mortimer B Davis Jewish General Hospital, Montreal, QC, Canada. · University Hospital Erlangen, Department of Obstetrics and Gynecology, Friedrich-Alexander-Universität Erlangen, Comprehensive Cancer Center Erlangen-Europäische Metropolregion Nuremberg, Erlangen, Germany. · Translational Research in Oncology, Biopark, Paris, France. · Translational Research in Oncology, Luis Alberto de Herrera, Montevideo, Uruguay. · F Hoffmann-La Roche, Basel, Switzerland. · Genentech, San Francisco, CA, USA. · Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. · David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. · Pubmed 29175149
  • Division of Hematology/Oncology, Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, California. · Division of Hematology/Oncology, Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, California. · Oncology Discovery Research, Lilly Research Laboratories, Indianapolis, Indiana. · Pubmed 29483214
  • Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA. Electronic address: · Division of General Internal Medicine and Health Services Research, Department of Medicine, University of California, Los Angeles, Los Angeles, CA. · Department of Surgery, University of California, Los Angeles, Los Angeles, CA. · Department of Radiology, University of California, Los Angeles, Los Angeles, CA. · Division of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA. · Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA. · Pubmed 29050918
2017
  • Department of Medicine and Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan. · Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain; Instituto Oncológico Baselga, Hospital Quirónsalud, Barcelona, Spain. · Department of Breast Oncology, Istituto Nazionale Tumouri Fondazione G Pascale, Naples, Italy. · Department of Breast Cancer, Beijing 307 Hospital of PLA, Beijing, China. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Department of Gynecology, University Hospital Schleswig-Holstein, Kiel, Germany. · Division of Medical Oncology, Ottawa Hospital Research Institute, Ottawa, ON, Canada. · Department of Radiation Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. · Medicine Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, BC Cancer Agency, Vancouver, BC, Canada. · Department of Breast Cancer and Reconstruction Surgery, Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland. · Department of Oncology, Ospedale di Macerata, Macerata, Italy. · Department of Surgery, Taipei Veterans General Hospital, National Yang Ming University, Taipei, Taiwan. · Division of Haematology-Oncology, Department of Medicine, University of California, Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Breast Oncology, Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan. · Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan. · Department of Medical Oncology, Université Catholique de Louvain, CHU UCL, Namur, Belgium. · Novartis Pharma SAS, Paris, France. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Syros Pharmaceuticals, Watertown, MA, USA. · Novartis Pharma AG, Basel, Switzerland. · Institut de Cancérologie de l'Ouest-René Gauducheau Centre de Recherche en Cancérologie, Nantes, France. · Pubmed 28576675
  • Department of Breast Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. · Department of Breast Surgery, Cancer Hospital of Fudan University, Shanghai, China. · University of California, Los Angeles (UCLA), Los Angeles, CA, USA. · Taipei Veterans General Hospital, National Yang Ming University, Taipei, Taiwan. · Department of Medical Oncology, Tumor Hospital of Harbin Medical University, Harbin, China. · Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China. · Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. · Jiangsu Cancer Hospital, 210009, Nanjing, China. · Department of Medical Oncology, Cancer Hospital and Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Beijing, China. · Department of Medical Oncology, Affiliated Zhejiang Cancer Hospital of Zhejiang Chinese Medical University Hangzhou, Hangzhou, Zhejiang Province, China. · Center for Breast Cancer, National Cancer Center, Gyeunggi-do, South Korea. · Department of Clinical Oncology, Tuen Mun Hospital, Tuen Mun, Hong Kong. · Novartis Pharma SAS, Rueil-Malmaison, France. · Novartis Pharma AG, Basel, Switzerland. · Beijing 307 Hospital of PLA, Beijing, China. · Pubmed 28399902
  • Department of Radiation Oncology, University of California, Los Angeles, 1223 16th Street, Suite 1100, Santa Monica, CA, 90404, USA. · Division of General Internal Medicine and Health Services Research, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. · Department of Surgery, University of California, Los Angeles, Los Angeles, CA, USA. · Department of Radiology, University of California, Los Angeles, Los Angeles, CA, USA. · Division of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. · Department of Radiation Oncology, University of California, Los Angeles, 1223 16th Street, Suite 1100, Santa Monica, CA, 90404, USA. · Pubmed 28702891
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco. · Icahn School of Medicine at Mount Sinai, New York, New York. · Wake Forest Baptist Health Medical Center, Wake Forest School of Medicine, Winston-Salem, North Carolina. · Jonsson Comprehensive Cancer Center, University of California, Los Angeles. · Weill Cornell Medical College, New York, New York. · Target Health Inc, New York, New York. · Dignitana AB, Lund, Sweden. · Wake Forest School of Medicine, Winston-Salem, North Carolina. · Columbia University, New York, New York10Now with the Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. · Pubmed 28196257
2016
  • David Geffen School of Medicine, UCLA, Los Angeles, California. · Pubmed 27379947
  • Department of Biostatistics, International Drug Development Institute (IDDI), Louvain La Neuve, Belgium · Division of Hematology-Oncology, University of California, Los Angeles (UCLA), Los Angeles, USA. · Department of Medical Oncology, Institut Gustave Roussy, Université Paris Sud, Villejuif, France. · Department of Breast Oncology, Beijing 307 Hospital of PLA, Beijing, China. · Department of Drug Development, Sarah Cannon Research Institute, Nashville, USA. · Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan. · Breast Surgery Clinic, Isarklinikum München, Munich, Germany. · Department of Scientific Development, Translational Research in Oncology (TRIO), Edmonton, Canada. · Pubmed 26861602
  • Division of Hematology and Oncology, UCLA, Santa Monica, California, USA. · Pubmed 26694831
  • Istituto Europeo di Oncologia, via Ripamonti 435, 20141, Milan, Italy. Electronic address: · Servicio Oncologia Médica, Vall d'Hebron University Hospital, Vall d'Hebron 119-129, 08035, Barcelona, Spain. · The University of Texas MD Anderson Cancer Center, 1400 Holcombe Blvd, Houston, TX, 77030, USA. · Istituto Oncologico Veneto, Via Gattamelata 64, 35128, Padua, Italy; University of Padova, Via Giustiniani 22, 35121, Padua, Italy. · University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands; Erasmus Medical Center Cancer Institute, Erasmus Medical Center, s-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Highlands Oncology Group, 3232 N North Hills Blvd, Fayetteville, AR, 72703, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School, 55 Fruit Street, Boston, MA, 02114, USA. · Oncología Médica, Hospital del Mar, Passeig Marítim 25-29, 08003, Barcelona, Spain. · Centre Jean Perrin, Unicancer and EA 4677 Université d'Auvergne, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA. · Novartis Institutes for BioMedical Research, 230 Massachusetts Avenue, Cambridge, MA, 02139, USA. · University of California, Los Angeles, 2825 Santa Monica Blvd, Suite 211, Santa Monica, CA, 90404, USA. · Pubmed 27336726
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain and Ramony Cajal University Hospital, Madrid, Spain. · University of California Los Angeles, Los Angeles, CA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · MD Anderson Cancer Center, Houston, TX, USA. · Sunnybrook Odette Cancer Centre, Toronto, Canada. · Merrimack Pharmaceuticals, Inc., 1 Kendall Square, Suite B7201, Cambridge, MA, 02139-1670, USA. · Merrimack Pharmaceuticals, Inc., 1 Kendall Square, Suite B7201, Cambridge, MA, 02139-1670, USA. · Sarah Cannon Research Institute, and Tennessee Oncology, PLLC, Nashville, TN, USA. · Pubmed 27259714
  • Fabrice André, Institut Gustav Roussy, INSERM Unit U981, Université Paris Sud, Villejuif, France · Sara Hurvitz and Dennis Slamon, University of California, Los Angeles, Los Angeles, CA · Angelica Fasolo, San Raffaele Scientific Institute, Milan, Italy · Ling-Ming Tseng, National Yang Ming University, Taipei, Taiwan · Guy Jerusalem, University of Liège, Liege, Belgium · Sharon Wilks, Cancer Care Center of South Texas, San Antonio, TX · Ruth O'Regan, University of Wisconsin Carbone Cancer Center, Madison, WI · Claudine Isaacs, Georgetown University, Washington DC · Masakazu Toi, Kyoto University, Sakyo-ku, Kyoto, Japan · Howard Burris, Sarah Cannon Research Institute, Nashville, TN · Wei He, Douglas Robinson, and Markus Riester, Novartis Institutes for BioMedical Research, Cambridge, MA · and Tetiana Taran and David Chen, Novartis Pharmaceuticals Corporation, East Hanover, NJ. · Pubmed 27091708
  • Brustzentrum der Universität München and Comprehensive Cancer Center of the Ludwig-Maximilians-Universität München, Munich, Germany. · National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; Taiwan Breast Cancer Consortium, Taipei, Taiwan. · University of California, Los Angeles, Los Angeles, CA, USA; Translational Research in Oncology, Los Angeles, CA, USA. · Taiwan Breast Cancer Consortium, Taipei, Taiwan; Taichung Veterans General Hospital, Taichung, Taiwan. · Fudan University Shanghai Cancer Center, Shanghai, China. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Comprehensive Breast Health Center, Rui Jin Hospital, Shanghai, China. · National Cancer Center, Goyang, South Korea. · Medical University, Gdansk, Poland. · Cancer Hospital of Harbin Medical University, Harbin, China. · Samsung Medical Center, Seoul, South Korea. · Comprehensive Cancer Centre, Medical University, Bialystok, Poland. · Peking Union Medical College Hospital, Beijing, China. · Taiwan Breast Cancer Consortium, Taipei, Taiwan; Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan. · Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany. · Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China; Peking Union Medical College, Beijing, China. Electronic address: · Institut Jules Bordet, Brussels, Belgium. · Pubmed 26822398
  • Celcuity LLC, Minneapolis, MN 55446, USA. · Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA. · Division of Hematology, Oncology and Transplantation, Departments of Medicine and Pharmacology and The Masonic Cancer Center, Minneapolis, MN 55455, USA. · Division of Hematology/Oncology and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA 90095, USA. · Pubmed 27713176
  • Department of Radiation Oncology, University of California, Los Angeles, CA, USA. · Department of Radiation Oncology, University of California, Los Angeles, CA, USA. · Department of Pathology and Laboratory Medicine, University of California, Los Angeles, CA, USA. · Santa Monica-UCLA Breast Center, University of California, Los Angeles, CA, USA. · Department of Surgery, Division of General Surgery, University of California, Los Angeles, CA, USA. · Department of Radiology, University of California, Los Angeles, CA, USA. · Department of Hematology and Oncology, University of California, Los Angeles, CA, USA. · Department of Plastic Surgery, University of California, Los Angeles, CA, USA. · Pubmed 27619940
  • David Geffen School of Medicine at University of California, Los Angeles (UCLA); Simms/Mann UCLA Center for Integrative Oncology; Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles; RAND Corporation, Santa Monica, CA; Campbell University College of Pharmacy and Health Sciences, Buies Creek; and Dusty Joy Foundation (LiveLung), High Point, NC. · Pubmed 27577617
  • Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Crump Institute for Molecular Imaging, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Biostatistics, Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Neurology, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065 USA; Department of Pharmacology, Weill-Cornell Medical College, New York, NY 10065, USA. · Division of Hematology/Oncology, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Oncology iMed, AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK. · Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; UCLA Metabolomics Center, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Crump Institute for Molecular Imaging, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; UCLA Metabolomics Center, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; UCLA Metabolomics Center, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, Los Angeles, CA 90095, USA. Electronic address: · Pubmed 26876179
2015
  • Vall d'Hebron Institute of Oncology, Barcelona, Spain and Ramon y Cajal University Hospital, Madrid, Spain. Electronic address: · Institut Curie, Paris, France. · National Cancer Center, Goyang-si, Republic of Korea. · Centre Antoine Lacassagne, Nice, France. · Centre Léon Bérard, Lyon, France. · University of California, Los Angeles, CA, USA. · Centre Oscar Lambret, Lille, France; University Hospital, Lille, France. · Hôpital Saint-Louis, Paris, France. · Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · National Center for Tumor Diseases, University Hospital, Heidelberg, Germany. · Severance Hospital, Sinchon-dong, Seodaemun-gu, Seoul, South Korea. · Centre Jean Perrin, Clermont-Ferrand, France. · Tampere University Hospital and University of Tampere, Tampere, Finland. · Sansum Clinic, Santa Barbara, CA, USA. · Università di Modena e Reggio Emilia, Modena, Italy. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Comprehensive Cancer Center, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland. · Boehringer Ingelheim, Paris, France. · Boehringer Ingelheim, Reims, France. · Pubmed 26596672
  • University of California, Los Angeles (UCLA), Los Angeles, CA, USA. Electronic address: · Department of Medical Oncology, Institut Gustave Roussy, Université Paris Sud, Villejuif, France. · Beijing 307 Hospital of PLA, Beijing, China. · Department of Breast Surgery, Cancer Hospital of Fudan University, Shanghai, China. · Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil. · Instituto Nacional de Enfermedades Neoplasicas, Surquillo, Lima, Peru. · Taipei Veterans General Hospital, National Yang Ming University, Taipei, Taiwan. · Department of Medical Oncology, Tumor Hospital of Harbin Medical University, Harbin, China. · Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China. · Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. · Department of Medical Oncology, University of Pretoria, Gauteng, South Africa. · Sarah Cannon Research Institute, Nashville, Tennessee, USA. · Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan. · International Drug Development Institute, Louvain La Neuve, Belgium. · Translational Research in Oncology (TRIO), Paris, France. · Translational Research in Oncology (TRIO), Edmonton, Canada. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Novartis Pharma AG, Basel, Switzerland. · University of California, Los Angeles (UCLA), Los Angeles, CA, USA. · Pubmed 26092818
  • Institut Curie, Paris, France. Electronic address: · University Hospital Leuven, Leuven, Belgium. Electronic address: · Medical University of Gdańsk, Gdańsk, Poland. Electronic address: · General Hospital Sint-Augustinus, Antwerp, Belgium. Electronic address: · Centre Léon Bérard, Lyon, France. Electronic address: · Helsinki University Central Hospital, Helsinki, Finland. Electronic address: · UCLA School of Medicine, Los Angeles, CA, USA. Electronic address: · Institut Paoli-Calmettes, Marseilles, France. Electronic address: · C.R.L.C. Val D'Aurelle, Montpellier, France. Electronic address: · Levine Cancer Institute, Charlotte, NC, USA. Electronic address: · CHU Sart Tilman, Liege, Belgium. Electronic address: · Kidwai Memorial Institute of Oncology, Bangalore, India. Electronic address: · Institut Claudius Régaud, Toulouse, France. Electronic address: · Complejo Hospitalario de Jaén, Jaén, Spain. Electronic address: · European Health Centre Otwock, Warszawa, Poland. Electronic address: · Corporació Sanitària Parc Taulí, Sabadell, Spain. Electronic address: · Amgen Inc., Thousand Oaks, CA, USA. Electronic address: · Amgen Inc., Thousand Oaks, CA, USA. Electronic address: · Amgen Inc., Thousand Oaks, CA, USA. Electronic address: · UCLA School of Medicine, Los Angeles, CA, USA. Electronic address: · Pubmed 25747197
  • Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. · PRO Unlimited, Inc., 1350 Old Bayshore Hwy Suite 350, Burlingame, CA, 94010, USA. · College of Social and Behavioral Sciences, School of Psychology, Walden University, 155 5th Avenue South, Minneapolis, MN, 55401, USA. · Department of Epidemiology and Biostatistics, University of California, San Francisco School of Medicine, 550 16th Street, 2nd Floor, San Francisco, CA, 94158, USA. · UCLA Jonsson Comprehensive Cancer Center, 2020 Santa Monica Blvd., Suite 580, Santa Monica, CA, 90404, USA. · Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. · Department of Epidemiology, Columbia University, 722 W 168th Street, New York, NY, 10032, USA. · Pharmaceutical Product Development, 980 Harvest Drive #130, Blue Bell, PA, 19422, USA. · Pubmed 26428301
  • Department of Hematology/Oncology, University of California, Los Angeles, 2825 Santa Monica Boulevard, Suite 211, Santa Monica, CA 90404, USA. · Pubmed 26323387
  • Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA, · Pubmed 25663547
  • From the David Geffen School of Medicine, Department of Medicine, Division of Endocrinology, Diabetes and Hypertension. · Division of Hematology-Oncology, and Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California 90095. · the Department of Pathology and Laboratory Medicine, Howard Hughes Medical Institute, UCLA, Los Angeles, California 90095. · the Orthopaedic Hospital Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, UCLA, Los Angeles, California 90095. · the Departments of Human Genetics and. · Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California 90095, Molecular and Medical Pharmacology, UCLA, Los Angeles, California 90095. · the Receptor Biology Section, Reproductive and Developmental Biology Laboratory, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina 27709, and. · Division of Hematology-Oncology, and Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California 90095, the Translational Research in Oncology-US. · From the David Geffen School of Medicine, Department of Medicine, Division of Endocrinology, Diabetes and Hypertension, Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California 90095, Iris Cantor-UCLA Women's Health Center, Los Angeles, California 90095 · Pubmed 25468909
2014
  • University of California, Division of Hematology-Oncology, Department of Medicine , 10945 Le Conte Avenue, PVUB Suite 3360, Los Angeles, CA 90095 , USA +1 310 829 5471 ; +1 310 829 6192 ; · Pubmed 24870559
  • University of California, Los Angeles, CA, United States. · UCR Thomas Haider/UCLA David Geffen School of Medicine, Los Angeles, CA, United States. · University of California, Los Angeles, CA, United States. Electronic address: · Pubmed 24560997
  • University of California Los Angeles, Los Angeles, California, USA; Analysis Group, Inc., Montreal, Quebec, Canada; Genentech Inc., South San Francisco, California, USA; Analysis Group, Inc., Boston, Massachusetts, USA. · University of California Los Angeles, Los Angeles, California, USA; Analysis Group, Inc., Montreal, Quebec, Canada; Genentech Inc., South San Francisco, California, USA; Analysis Group, Inc., Boston, Massachusetts, USA · Pubmed 25085897
  • UCLA Jonsson Comprehensive Cancer Center, Los Angeles, California. · Pubmed 25003356
  • Authors' Affiliations: Division of Hematology/Oncology, Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, California; · Authors' Affiliations: Division of Hematology/Oncology, Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, California; · Novartis Pharmaceuticals, Cambridge, Massachusetts; and. · Novartis Pharmaceuticals, Basel, Switzerland. · Pubmed 24879796
2013
  • University of California at Los Angeles, Los Angeles, CA 90095, USA. · Pubmed 22658319
  • Department of Medicine, Hematology/Oncology, UCLA Jonsson Comprehensive Cancer Center, 10945 Le Conte Avenue, PVUB Suite 3360, Los Angeles, CA, 90095, USA, · Pubmed 24101324
  • University of California, Los Angeles Jonsson Comprehensive Cancer Center and Translational Oncology Research International, Los Angeles, CA, USA. · Pubmed 23382472
  • University of California, Los Angeles, California. · Pubmed 24218050
2012
  • University of California at Los Angeles, Los Angeles, California, USA. · Pubmed 22504044
2011
  • Department of Medicine, Division of Hematology-Oncology, University of California-Los Angeles School of Medicine, Los Angeles, CA 90095-7077, USA. · Pubmed 21315516
2018
  • From the University of Texas M.D. Anderson Cancer Center, Houston (J.K.L.), and the Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas (J.L.B.) - both in Texas · University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (H.S.R.), and Pfizer (R.G.W.Q., D.M., I.C.T., A.L.H.), San Francisco, University of California, Los Angeles, Los Angeles (S.A.H.), and Kaiser Permanente, Northern California, Vallejo (L.F.) - all in California · the Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technische Universität München (J.E.), and Interdisziplinäres Onkologisches Zentrum München (W.E.) - both in Munich, Germany · Institut Paoli-Calmettes, Marseille (A.G.), and Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse, Toulouse (H.R.) - both in France · Seoul National University Hospital (K.-H.L.) and Samsung Medical Center (Y.-H.I.) - both in Seoul, South Korea · Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel (R.Y.) · Banner M.D. Anderson Cancer Center, Gilbert, AZ (L.A.M.) · and Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red Oncología, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid (M.M.). · Pubmed 30110579
2017
  • From the David Geffen School of Medicine, University of California, Los Angeles, CA; BC Cancer Agency, University of British Columbia, Vancouver, BC, Canada; Dana-Farber Cancer Institute, Boston, MA. · Pubmed 28561711
2014
  • Division of Hematology Oncology, University of California, Los Angeles, 10945 Le Conte Avenue, PVUB Suite 3360, Los Angeles, CA, 90095, USA. · Pubmed 24469856
  • Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles, CA 90404, USA. Electronic address: · Pubmed 24011786
2013
  • Department of Medicine, Division of Hematology-Oncology, University of California at Los Angeles, CA, USA. · Pubmed 23469968
2011
  • University of California at Los Angeles, Los Angeles,California, USA. · Pubmed 21500375
Probable:    Veterans Health System      
2016
  • David Geffen School of Medicine at University of California, Los Angeles (UCLA); Simms/Mann UCLA Center for Integrative Oncology; Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles; RAND Corporation, Santa Monica, CA; Campbell University College of Pharmacy and Health Sciences, Buies Creek; and Dusty Joy Foundation (LiveLung), High Point, NC. · Pubmed 27577617
Probable:    RAND Corporation      
2016
  • David Geffen School of Medicine at University of California, Los Angeles (UCLA); Simms/Mann UCLA Center for Integrative Oncology; Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles; RAND Corporation, Santa Monica, CA; Campbell University College of Pharmacy and Health Sciences, Buies Creek; and Dusty Joy Foundation (LiveLung), High Point, NC. · Pubmed 27577617
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 58 total) written by Sara A. Hurvitz about Breast Neoplasms:

  • Advances in Targeted Therapies for Triple-Negative Breast Cancer. 2019
  • Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer. 2019
  • Is the duration of adjuvant trastuzumab debate still clinically relevant? 2019
  • Dose intensification of chemotherapy for early breast cancer in the age of de-escalation. 2019
  • Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: patient-reported outcomes from the ABRAZO phase 2 trial. 2018
  • Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2. 2018
  • Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation. 2018
  • Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer: The BOLERO-6 Randomized Clinical Trial. 2018
  • Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial. 2018
  • Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial. 2018
Show List of Full Article Records
Google Searches

Learn more about Sara A. Hurvitz using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
UCLA
Veterans Health System
RAND Corporation
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
UCLA
2019
  • Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, 2336 Santa Monica, Suite 304, Santa Monica, Los Angeles, CA, 90404, USA. · Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, 2336 Santa Monica, Suite 304, Santa Monica, Los Angeles, CA, 90404, USA. · Pubmed 31254268
  • From Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine (S.-A.I.), the Yonsei Cancer Center, Yonsei University Health System (J.S.), and the Asan Medical Center, University of Ulsan College of Medicine (K.-H.J.), Seoul, and the Center for Breast Cancer, National Cancer Center, Gyeonggi-do (K.-S.L.) - all in South Korea · National Taiwan University Hospital, Taipei, Taiwan (Y.-S.L.) · Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston (A.B.) · the Breast Center, Department of Obstetrics and Gynecology, Ludwig-Maximilians-University Munich, Munich, Germany (N.H.) · the Division of Medical Senology, Istituto Europeo di Oncologia, Milan (M.C.) · Hospital de Caridade de Ijuí, CACON, Ijuí, Brazil (F.F.) · the Organisation for Oncology and Translational Research, Hong Kong (L.C.) · Centro Oncológico Estatal, Instituto de Seguridad Social del Estado de México y Municipios, Toluca, Mexico (S.C.-G.) · Institut Català d'Oncologia, Hospital de Sant Joan Despí Moisès Broggi, Barcelona (R.V.-V.) · Novartis Pharmaceuticals, East Hanover, NJ (A.C., K.R.-L., T.T.) · Novartis, Basel, Switzerland (G.H., I.G.) · the UCLA Jonsson Comprehensive Cancer Center, Los Angeles (S.H.) · and the University of Texas M.D. Anderson Cancer Center, Houston (D.T.). · Pubmed 31166679
  • David Geffen School of Medicine at University of California, Los Angeles, CA 90095, USA. Electronic address: · Pubmed 31178153
  • Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Santa Monica, CA 90404, USA. Electronic address: · Pubmed 30739744
2018
  • University of California, Los Angeles, 10945 Le Conte Avenue PVUB 3360, Los Angeles, CA, 90095, USA. Electronic address: · Pfizer Inc., 525 Market Street, 36th Floor, San Francisco, CA, 94105, USA. Electronic address: · The Royal Marsden Hospital-The Royal Marsden NHS Foundation Trust, Fulham Road, Chelsea, London, SW3 6JJ, UK. Electronic address: · Stanford University School of Medicine, 900 Blake Wilbur Drive, 1st Floor, Palo Alto, CA, 94304, USA. Electronic address: · University of California San Francisco Comprehensive Cancer Center, 1600 Divisadero Street, 3rd Floor, San Francisco, CA, 94115, USA. Electronic address: · Centre Oscar Lambret, 3 Rue Frédéric Combemale, 59000, Lille, France. Electronic address: · Klinikum Rechts der Isar, Technische Universität München, Ismaningerstrasse 22, 81675, Munich, Germany. Electronic address: · Universitäts-Frauenklinik Calwerstr. 7, 72076, Tübingen, Germany; Eberhard Karls University, Geschwister-Scholl-Platz, 72074, Tübingen, Germany. Electronic address: · Banner MD Anderson Cancer Center, 2946 E Banner Gateway Dr, Gilbert, AZ, 85234, USA. Electronic address: · Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology, CELLEX CENTER, C/ Natzaret, 115-117, 08035, Barcelona, Spain. Electronic address: · University Hospital Erlangen, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Universitätsstraße 21-23, 91054 Erlangen Erlangen, Germany. Electronic address: · Pfizer Inc., 525 Market Street, 36th Floor, San Francisco, CA, 94105, USA. Electronic address: · Pfizer Inc., 525 Market Street, 36th Floor, San Francisco, CA, 94105, USA. Electronic address: · Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA. Electronic address: · The NIHR Manchester Clinical Research Facility at The Christie & Division of Cancer Sciences University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. Electronic address: · Pubmed 30359909
  • Centre René Gauducheau, Institut de Cancérologie de L'Ouest, Saint Herblain, France. Electronic address: · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. · Department of Breast Oncology, Aichi Cancer Center, Nagoya, Japan. · Division of Medical Oncology, Ottawa Hospital Research Institute, Ottawa, Canada. · Breast Oncology Center, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. · Medical Oncology Clinic, Institut Jules Bordet, Brussels, Belgium. · Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Oncology Center, Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology (MCMCC), Warsaw, Poland. · Macerata Hospital, Macerata, Italy. · Department of Surgery, Taipei-Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan. · UCLA Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, USA. · Department of Surgery and Breast Oncology, National Hospital Organization Osaka National Hospital, Osaka, Japan. · Institute of Oncology, Ramón y Cajal University Hospital, Madrid, Spain; Breast Cancer Research Program, Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Breast Cancer Department, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Vanderbilt-Ingram Cancer Center, Department of Medicine, Vanderbilt University, Nashville, USA. · Department of Breast Cancer, Beijing 307 Hospital of PLA, Beijing, China. · Medical Center, University Hospital Schleswig-Holstein, Kiel, Germany. · Novartis Pharma S.A.S., Paris, France. · Novartis Institutes for BioMedical Research, Cambridge, USA. · Novartis Pharmaceuticals Corporation, East Hanover, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 30241001
  • CHU Sart Tilman Liege and Liege University, Liege, Belgium. · Royal Melbourne Hospital, Victoria, Australia. · Jonsson Comprehensive Cancer Center, University of California, Los Angeles. · Sarah Cannon Research Institute, Nashville, Tennessee. · Tennessee Oncology, PLLC, Nashville, Tennessee. · Russian Cancer Research Center, Moscow, Russia. · Copenhagen University Hospital, Copenhagen, Denmark. · Rainier Hematology-Oncology, Northwest Medical Specialties, Tacoma, Washington. · Cerrahpaşa School of Medicine, Istanbul University, Istanbul, Turkey. · Uzsoki Teaching Hospital, Budapest, Hungary. · Institute of Clinical Research, Odense University Hospital, University of Southern Denmark, Odense, Denmark. · Novartis Pharmaceuticals Corporation, East Hanover, New Jersey. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharma SAS, Paris, France. · Pubmed 29862411
  • The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Seoul National University Hospital, Cancer Research Institute, and Seoul National University College of Medicine, Seoul, South Korea. · Division of Medical Senology, Istituto Europeo di Oncologia, Milan, Italy. · Hospital de Caridade de Ijuí, Cacon, Ijuí, Brazil. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. · Breast Center, Department of Obstetrics and Gynaecology, University of Munich, Munich, Germany. · UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Organisation for Oncology and Translational Research, Hong Kong Special Administrative Region, China. · Yonsei Cancer Center, Yonsei University Health System, Seoul, South Korea. · Research Institute and Hospital, National Cancer Center, Goyang, South Korea. · Centro Oncológico Estatal, Instituto de Seguridad Social del Estado de México y Municipios, Toluca, Mexico. · Institut Català d'Oncologia, Hospital Moisès Broggi, Barcelona, Spain. · Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · HCG Curie Centre of Oncology and Kidwai Memorial Institute of Oncology, Bangalore, India. · University of Ottawa, Ottawa, ON, Canada. · Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Breast Unit, Kliniken Essen-Mitte, Essen, Germany. · American University of Beirut Medical Center, Beirut, Lebanon. · Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan. · Novartis, East Hanover, NJ, USA. · Novartis, Basel, Switzerland. · National Taiwan University Hospital, Taipei, Taiwan. Electronic address: · Pubmed 29804902
  • David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. Electronic address: · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CiberOnc, GEICAM, Madrid, Spain. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, Korea. · National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. · Breast Center, University of Munich (LMU), Munich, Germany. · Moscow City Oncology Hospital 62, Moscow, Russia. · Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Centre René Gauducheau, St Herblain cedex, France. · McGill University, Sir Mortimer B Davis Jewish General Hospital, Montreal, QC, Canada. · University Hospital Erlangen, Department of Obstetrics and Gynecology, Friedrich-Alexander-Universität Erlangen, Comprehensive Cancer Center Erlangen-Europäische Metropolregion Nuremberg, Erlangen, Germany. · Translational Research in Oncology, Biopark, Paris, France. · Translational Research in Oncology, Luis Alberto de Herrera, Montevideo, Uruguay. · F Hoffmann-La Roche, Basel, Switzerland. · Genentech, San Francisco, CA, USA. · Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. · David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. · Pubmed 29175149
  • Division of Hematology/Oncology, Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, California. · Division of Hematology/Oncology, Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, California. · Oncology Discovery Research, Lilly Research Laboratories, Indianapolis, Indiana. · Pubmed 29483214
  • Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA. Electronic address: · Division of General Internal Medicine and Health Services Research, Department of Medicine, University of California, Los Angeles, Los Angeles, CA. · Department of Surgery, University of California, Los Angeles, Los Angeles, CA. · Department of Radiology, University of California, Los Angeles, Los Angeles, CA. · Division of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA. · Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA. · Pubmed 29050918
2017
  • Department of Medicine and Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan. · Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain; Instituto Oncológico Baselga, Hospital Quirónsalud, Barcelona, Spain. · Department of Breast Oncology, Istituto Nazionale Tumouri Fondazione G Pascale, Naples, Italy. · Department of Breast Cancer, Beijing 307 Hospital of PLA, Beijing, China. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Department of Gynecology, University Hospital Schleswig-Holstein, Kiel, Germany. · Division of Medical Oncology, Ottawa Hospital Research Institute, Ottawa, ON, Canada. · Department of Radiation Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. · Medicine Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, BC Cancer Agency, Vancouver, BC, Canada. · Department of Breast Cancer and Reconstruction Surgery, Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland. · Department of Oncology, Ospedale di Macerata, Macerata, Italy. · Department of Surgery, Taipei Veterans General Hospital, National Yang Ming University, Taipei, Taiwan. · Division of Haematology-Oncology, Department of Medicine, University of California, Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Breast Oncology, Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan. · Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan. · Department of Medical Oncology, Université Catholique de Louvain, CHU UCL, Namur, Belgium. · Novartis Pharma SAS, Paris, France. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Syros Pharmaceuticals, Watertown, MA, USA. · Novartis Pharma AG, Basel, Switzerland. · Institut de Cancérologie de l'Ouest-René Gauducheau Centre de Recherche en Cancérologie, Nantes, France. · Pubmed 28576675
  • Department of Breast Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. · Department of Breast Surgery, Cancer Hospital of Fudan University, Shanghai, China. · University of California, Los Angeles (UCLA), Los Angeles, CA, USA. · Taipei Veterans General Hospital, National Yang Ming University, Taipei, Taiwan. · Department of Medical Oncology, Tumor Hospital of Harbin Medical University, Harbin, China. · Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China. · Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. · Jiangsu Cancer Hospital, 210009, Nanjing, China. · Department of Medical Oncology, Cancer Hospital and Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Beijing, China. · Department of Medical Oncology, Affiliated Zhejiang Cancer Hospital of Zhejiang Chinese Medical University Hangzhou, Hangzhou, Zhejiang Province, China. · Center for Breast Cancer, National Cancer Center, Gyeunggi-do, South Korea. · Department of Clinical Oncology, Tuen Mun Hospital, Tuen Mun, Hong Kong. · Novartis Pharma SAS, Rueil-Malmaison, France. · Novartis Pharma AG, Basel, Switzerland. · Beijing 307 Hospital of PLA, Beijing, China. · Pubmed 28399902
  • Department of Radiation Oncology, University of California, Los Angeles, 1223 16th Street, Suite 1100, Santa Monica, CA, 90404, USA. · Division of General Internal Medicine and Health Services Research, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. · Department of Surgery, University of California, Los Angeles, Los Angeles, CA, USA. · Department of Radiology, University of California, Los Angeles, Los Angeles, CA, USA. · Division of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. · Department of Radiation Oncology, University of California, Los Angeles, 1223 16th Street, Suite 1100, Santa Monica, CA, 90404, USA. · Pubmed 28702891
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco. · Icahn School of Medicine at Mount Sinai, New York, New York. · Wake Forest Baptist Health Medical Center, Wake Forest School of Medicine, Winston-Salem, North Carolina. · Jonsson Comprehensive Cancer Center, University of California, Los Angeles. · Weill Cornell Medical College, New York, New York. · Target Health Inc, New York, New York. · Dignitana AB, Lund, Sweden. · Wake Forest School of Medicine, Winston-Salem, North Carolina. · Columbia University, New York, New York10Now with the Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. · Pubmed 28196257
2016
  • David Geffen School of Medicine, UCLA, Los Angeles, California. · Pubmed 27379947
  • Department of Biostatistics, International Drug Development Institute (IDDI), Louvain La Neuve, Belgium · Division of Hematology-Oncology, University of California, Los Angeles (UCLA), Los Angeles, USA. · Department of Medical Oncology, Institut Gustave Roussy, Université Paris Sud, Villejuif, France. · Department of Breast Oncology, Beijing 307 Hospital of PLA, Beijing, China. · Department of Drug Development, Sarah Cannon Research Institute, Nashville, USA. · Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan. · Breast Surgery Clinic, Isarklinikum München, Munich, Germany. · Department of Scientific Development, Translational Research in Oncology (TRIO), Edmonton, Canada. · Pubmed 26861602
  • Division of Hematology and Oncology, UCLA, Santa Monica, California, USA. · Pubmed 26694831
  • Istituto Europeo di Oncologia, via Ripamonti 435, 20141, Milan, Italy. Electronic address: · Servicio Oncologia Médica, Vall d'Hebron University Hospital, Vall d'Hebron 119-129, 08035, Barcelona, Spain. · The University of Texas MD Anderson Cancer Center, 1400 Holcombe Blvd, Houston, TX, 77030, USA. · Istituto Oncologico Veneto, Via Gattamelata 64, 35128, Padua, Italy; University of Padova, Via Giustiniani 22, 35121, Padua, Italy. · University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands; Erasmus Medical Center Cancer Institute, Erasmus Medical Center, s-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. · Highlands Oncology Group, 3232 N North Hills Blvd, Fayetteville, AR, 72703, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School, 55 Fruit Street, Boston, MA, 02114, USA. · Oncología Médica, Hospital del Mar, Passeig Marítim 25-29, 08003, Barcelona, Spain. · Centre Jean Perrin, Unicancer and EA 4677 Université d'Auvergne, 58 rue Montalembert, 63011, Clermont-Ferrand, France. · Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA. · Novartis Institutes for BioMedical Research, 230 Massachusetts Avenue, Cambridge, MA, 02139, USA. · University of California, Los Angeles, 2825 Santa Monica Blvd, Suite 211, Santa Monica, CA, 90404, USA. · Pubmed 27336726
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain and Ramony Cajal University Hospital, Madrid, Spain. · University of California Los Angeles, Los Angeles, CA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · MD Anderson Cancer Center, Houston, TX, USA. · Sunnybrook Odette Cancer Centre, Toronto, Canada. · Merrimack Pharmaceuticals, Inc., 1 Kendall Square, Suite B7201, Cambridge, MA, 02139-1670, USA. · Merrimack Pharmaceuticals, Inc., 1 Kendall Square, Suite B7201, Cambridge, MA, 02139-1670, USA. · Sarah Cannon Research Institute, and Tennessee Oncology, PLLC, Nashville, TN, USA. · Pubmed 27259714
  • Fabrice André, Institut Gustav Roussy, INSERM Unit U981, Université Paris Sud, Villejuif, France · Sara Hurvitz and Dennis Slamon, University of California, Los Angeles, Los Angeles, CA · Angelica Fasolo, San Raffaele Scientific Institute, Milan, Italy · Ling-Ming Tseng, National Yang Ming University, Taipei, Taiwan · Guy Jerusalem, University of Liège, Liege, Belgium · Sharon Wilks, Cancer Care Center of South Texas, San Antonio, TX · Ruth O'Regan, University of Wisconsin Carbone Cancer Center, Madison, WI · Claudine Isaacs, Georgetown University, Washington DC · Masakazu Toi, Kyoto University, Sakyo-ku, Kyoto, Japan · Howard Burris, Sarah Cannon Research Institute, Nashville, TN · Wei He, Douglas Robinson, and Markus Riester, Novartis Institutes for BioMedical Research, Cambridge, MA · and Tetiana Taran and David Chen, Novartis Pharmaceuticals Corporation, East Hanover, NJ. · Pubmed 27091708
  • Brustzentrum der Universität München and Comprehensive Cancer Center of the Ludwig-Maximilians-Universität München, Munich, Germany. · National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; Taiwan Breast Cancer Consortium, Taipei, Taiwan. · University of California, Los Angeles, Los Angeles, CA, USA; Translational Research in Oncology, Los Angeles, CA, USA. · Taiwan Breast Cancer Consortium, Taipei, Taiwan; Taichung Veterans General Hospital, Taichung, Taiwan. · Fudan University Shanghai Cancer Center, Shanghai, China. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Comprehensive Breast Health Center, Rui Jin Hospital, Shanghai, China. · National Cancer Center, Goyang, South Korea. · Medical University, Gdansk, Poland. · Cancer Hospital of Harbin Medical University, Harbin, China. · Samsung Medical Center, Seoul, South Korea. · Comprehensive Cancer Centre, Medical University, Bialystok, Poland. · Peking Union Medical College Hospital, Beijing, China. · Taiwan Breast Cancer Consortium, Taipei, Taiwan; Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan. · Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany. · Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China; Peking Union Medical College, Beijing, China. Electronic address: · Institut Jules Bordet, Brussels, Belgium. · Pubmed 26822398
  • Celcuity LLC, Minneapolis, MN 55446, USA. · Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA. · Division of Hematology, Oncology and Transplantation, Departments of Medicine and Pharmacology and The Masonic Cancer Center, Minneapolis, MN 55455, USA. · Division of Hematology/Oncology and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA 90095, USA. · Pubmed 27713176
  • Department of Radiation Oncology, University of California, Los Angeles, CA, USA. · Department of Radiation Oncology, University of California, Los Angeles, CA, USA. · Department of Pathology and Laboratory Medicine, University of California, Los Angeles, CA, USA. · Santa Monica-UCLA Breast Center, University of California, Los Angeles, CA, USA. · Department of Surgery, Division of General Surgery, University of California, Los Angeles, CA, USA. · Department of Radiology, University of California, Los Angeles, CA, USA. · Department of Hematology and Oncology, University of California, Los Angeles, CA, USA. · Department of Plastic Surgery, University of California, Los Angeles, CA, USA. · Pubmed 27619940
  • David Geffen School of Medicine at University of California, Los Angeles (UCLA); Simms/Mann UCLA Center for Integrative Oncology; Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles; RAND Corporation, Santa Monica, CA; Campbell University College of Pharmacy and Health Sciences, Buies Creek; and Dusty Joy Foundation (LiveLung), High Point, NC. · Pubmed 27577617
  • Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Crump Institute for Molecular Imaging, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Biostatistics, Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Neurology, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065 USA; Department of Pharmacology, Weill-Cornell Medical College, New York, NY 10065, USA. · Division of Hematology/Oncology, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Oncology iMed, AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK. · Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; UCLA Metabolomics Center, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Crump Institute for Molecular Imaging, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; UCLA Metabolomics Center, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; UCLA Metabolomics Center, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, Los Angeles, CA 90095, USA. Electronic address: · Pubmed 26876179
2015
  • Vall d'Hebron Institute of Oncology, Barcelona, Spain and Ramon y Cajal University Hospital, Madrid, Spain. Electronic address: · Institut Curie, Paris, France. · National Cancer Center, Goyang-si, Republic of Korea. · Centre Antoine Lacassagne, Nice, France. · Centre Léon Bérard, Lyon, France. · University of California, Los Angeles, CA, USA. · Centre Oscar Lambret, Lille, France; University Hospital, Lille, France. · Hôpital Saint-Louis, Paris, France. · Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · National Center for Tumor Diseases, University Hospital, Heidelberg, Germany. · Severance Hospital, Sinchon-dong, Seodaemun-gu, Seoul, South Korea. · Centre Jean Perrin, Clermont-Ferrand, France. · Tampere University Hospital and University of Tampere, Tampere, Finland. · Sansum Clinic, Santa Barbara, CA, USA. · Università di Modena e Reggio Emilia, Modena, Italy. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Comprehensive Cancer Center, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland. · Boehringer Ingelheim, Paris, France. · Boehringer Ingelheim, Reims, France. · Pubmed 26596672
  • University of California, Los Angeles (UCLA), Los Angeles, CA, USA. Electronic address: · Department of Medical Oncology, Institut Gustave Roussy, Université Paris Sud, Villejuif, France. · Beijing 307 Hospital of PLA, Beijing, China. · Department of Breast Surgery, Cancer Hospital of Fudan University, Shanghai, China. · Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil. · Instituto Nacional de Enfermedades Neoplasicas, Surquillo, Lima, Peru. · Taipei Veterans General Hospital, National Yang Ming University, Taipei, Taiwan. · Department of Medical Oncology, Tumor Hospital of Harbin Medical University, Harbin, China. · Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China. · Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. · Department of Medical Oncology, University of Pretoria, Gauteng, South Africa. · Sarah Cannon Research Institute, Nashville, Tennessee, USA. · Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan. · International Drug Development Institute, Louvain La Neuve, Belgium. · Translational Research in Oncology (TRIO), Paris, France. · Translational Research in Oncology (TRIO), Edmonton, Canada. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Novartis Pharma AG, Basel, Switzerland. · University of California, Los Angeles (UCLA), Los Angeles, CA, USA. · Pubmed 26092818
  • Institut Curie, Paris, France. Electronic address: · University Hospital Leuven, Leuven, Belgium. Electronic address: · Medical University of Gdańsk, Gdańsk, Poland. Electronic address: · General Hospital Sint-Augustinus, Antwerp, Belgium. Electronic address: · Centre Léon Bérard, Lyon, France. Electronic address: · Helsinki University Central Hospital, Helsinki, Finland. Electronic address: · UCLA School of Medicine, Los Angeles, CA, USA. Electronic address: · Institut Paoli-Calmettes, Marseilles, France. Electronic address: · C.R.L.C. Val D'Aurelle, Montpellier, France. Electronic address: · Levine Cancer Institute, Charlotte, NC, USA. Electronic address: · CHU Sart Tilman, Liege, Belgium. Electronic address: · Kidwai Memorial Institute of Oncology, Bangalore, India. Electronic address: · Institut Claudius Régaud, Toulouse, France. Electronic address: · Complejo Hospitalario de Jaén, Jaén, Spain. Electronic address: · European Health Centre Otwock, Warszawa, Poland. Electronic address: · Corporació Sanitària Parc Taulí, Sabadell, Spain. Electronic address: · Amgen Inc., Thousand Oaks, CA, USA. Electronic address: · Amgen Inc., Thousand Oaks, CA, USA. Electronic address: · Amgen Inc., Thousand Oaks, CA, USA. Electronic address: · UCLA School of Medicine, Los Angeles, CA, USA. Electronic address: · Pubmed 25747197
  • Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. · PRO Unlimited, Inc., 1350 Old Bayshore Hwy Suite 350, Burlingame, CA, 94010, USA. · College of Social and Behavioral Sciences, School of Psychology, Walden University, 155 5th Avenue South, Minneapolis, MN, 55401, USA. · Department of Epidemiology and Biostatistics, University of California, San Francisco School of Medicine, 550 16th Street, 2nd Floor, San Francisco, CA, 94158, USA. · UCLA Jonsson Comprehensive Cancer Center, 2020 Santa Monica Blvd., Suite 580, Santa Monica, CA, 90404, USA. · Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. · Department of Epidemiology, Columbia University, 722 W 168th Street, New York, NY, 10032, USA. · Pharmaceutical Product Development, 980 Harvest Drive #130, Blue Bell, PA, 19422, USA. · Pubmed 26428301
  • Department of Hematology/Oncology, University of California, Los Angeles, 2825 Santa Monica Boulevard, Suite 211, Santa Monica, CA 90404, USA. · Pubmed 26323387
  • Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA, · Pubmed 25663547
  • From the David Geffen School of Medicine, Department of Medicine, Division of Endocrinology, Diabetes and Hypertension. · Division of Hematology-Oncology, and Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California 90095. · the Department of Pathology and Laboratory Medicine, Howard Hughes Medical Institute, UCLA, Los Angeles, California 90095. · the Orthopaedic Hospital Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, UCLA, Los Angeles, California 90095. · the Departments of Human Genetics and. · Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California 90095, Molecular and Medical Pharmacology, UCLA, Los Angeles, California 90095. · the Receptor Biology Section, Reproductive and Developmental Biology Laboratory, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina 27709, and. · Division of Hematology-Oncology, and Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California 90095, the Translational Research in Oncology-US. · From the David Geffen School of Medicine, Department of Medicine, Division of Endocrinology, Diabetes and Hypertension, Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California 90095, Iris Cantor-UCLA Women's Health Center, Los Angeles, California 90095 · Pubmed 25468909
2014
  • University of California, Division of Hematology-Oncology, Department of Medicine , 10945 Le Conte Avenue, PVUB Suite 3360, Los Angeles, CA 90095 , USA +1 310 829 5471 ; +1 310 829 6192 ; · Pubmed 24870559
  • University of California, Los Angeles, CA, United States. · UCR Thomas Haider/UCLA David Geffen School of Medicine, Los Angeles, CA, United States. · University of California, Los Angeles, CA, United States. Electronic address: · Pubmed 24560997
  • University of California Los Angeles, Los Angeles, California, USA; Analysis Group, Inc., Montreal, Quebec, Canada; Genentech Inc., South San Francisco, California, USA; Analysis Group, Inc., Boston, Massachusetts, USA. · University of California Los Angeles, Los Angeles, California, USA; Analysis Group, Inc., Montreal, Quebec, Canada; Genentech Inc., South San Francisco, California, USA; Analysis Group, Inc., Boston, Massachusetts, USA · Pubmed 25085897
  • UCLA Jonsson Comprehensive Cancer Center, Los Angeles, California. · Pubmed 25003356
  • Authors' Affiliations: Division of Hematology/Oncology, Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, California; · Authors' Affiliations: Division of Hematology/Oncology, Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, California; · Novartis Pharmaceuticals, Cambridge, Massachusetts; and. · Novartis Pharmaceuticals, Basel, Switzerland. · Pubmed 24879796
2013
  • University of California at Los Angeles, Los Angeles, CA 90095, USA. · Pubmed 22658319
  • Department of Medicine, Hematology/Oncology, UCLA Jonsson Comprehensive Cancer Center, 10945 Le Conte Avenue, PVUB Suite 3360, Los Angeles, CA, 90095, USA, · Pubmed 24101324
  • University of California, Los Angeles Jonsson Comprehensive Cancer Center and Translational Oncology Research International, Los Angeles, CA, USA. · Pubmed 23382472
  • University of California, Los Angeles, California. · Pubmed 24218050
2012
  • University of California at Los Angeles, Los Angeles, California, USA. · Pubmed 22504044
2011
  • Department of Medicine, Division of Hematology-Oncology, University of California-Los Angeles School of Medicine, Los Angeles, CA 90095-7077, USA. · Pubmed 21315516
2018
  • From the University of Texas M.D. Anderson Cancer Center, Houston (J.K.L.), and the Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas (J.L.B.) - both in Texas · University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (H.S.R.), and Pfizer (R.G.W.Q., D.M., I.C.T., A.L.H.), San Francisco, University of California, Los Angeles, Los Angeles (S.A.H.), and Kaiser Permanente, Northern California, Vallejo (L.F.) - all in California · the Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technische Universität München (J.E.), and Interdisziplinäres Onkologisches Zentrum München (W.E.) - both in Munich, Germany · Institut Paoli-Calmettes, Marseille (A.G.), and Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse, Toulouse (H.R.) - both in France · Seoul National University Hospital (K.-H.L.) and Samsung Medical Center (Y.-H.I.) - both in Seoul, South Korea · Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel (R.Y.) · Banner M.D. Anderson Cancer Center, Gilbert, AZ (L.A.M.) · and Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red Oncología, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid (M.M.). · Pubmed 30110579
2017
  • From the David Geffen School of Medicine, University of California, Los Angeles, CA; BC Cancer Agency, University of British Columbia, Vancouver, BC, Canada; Dana-Farber Cancer Institute, Boston, MA. · Pubmed 28561711
2014
  • Division of Hematology Oncology, University of California, Los Angeles, 10945 Le Conte Avenue, PVUB Suite 3360, Los Angeles, CA, 90095, USA. · Pubmed 24469856
  • Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles, CA 90404, USA. Electronic address: · Pubmed 24011786
2013
  • Department of Medicine, Division of Hematology-Oncology, University of California at Los Angeles, CA, USA. · Pubmed 23469968
2011
  • University of California at Los Angeles, Los Angeles,California, USA. · Pubmed 21500375
Veterans Health System
2016
  • David Geffen School of Medicine at University of California, Los Angeles (UCLA); Simms/Mann UCLA Center for Integrative Oncology; Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles; RAND Corporation, Santa Monica, CA; Campbell University College of Pharmacy and Health Sciences, Buies Creek; and Dusty Joy Foundation (LiveLung), High Point, NC. · Pubmed 27577617
RAND Corporation
2016
  • David Geffen School of Medicine at University of California, Los Angeles (UCLA); Simms/Mann UCLA Center for Integrative Oncology; Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles; RAND Corporation, Santa Monica, CA; Campbell University College of Pharmacy and Health Sciences, Buies Creek; and Dusty Joy Foundation (LiveLung), High Point, NC. · Pubmed 27577617
University of California San Francisco
2014
  • University of California Los Angeles, Los Angeles, California, USA; Analysis Group, Inc., Montreal, Quebec, Canada; Genentech Inc., South San Francisco, California, USA; Analysis Group, Inc., Boston, Massachusetts, USA. · University of California Los Angeles, Los Angeles, California, USA; Analysis Group, Inc., Montreal, Quebec, Canada; Genentech Inc., South San Francisco, California, USA; Analysis Group, Inc., Boston, Massachusetts, USA · Pubmed 25085897
2018
  • From the University of Texas M.D. Anderson Cancer Center, Houston (J.K.L.), and the Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas (J.L.B.) - both in Texas · University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (H.S.R.), and Pfizer (R.G.W.Q., D.M., I.C.T., A.L.H.), San Francisco, University of California, Los Angeles, Los Angeles (S.A.H.), and Kaiser Permanente, Northern California, Vallejo (L.F.) - all in California · the Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technische Universität München (J.E.), and Interdisziplinäres Onkologisches Zentrum München (W.E.) - both in Munich, Germany · Institut Paoli-Calmettes, Marseille (A.G.), and Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse, Toulouse (H.R.) - both in France · Seoul National University Hospital (K.-H.L.) and Samsung Medical Center (Y.-H.I.) - both in Seoul, South Korea · Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel (R.Y.) · Banner M.D. Anderson Cancer Center, Gilbert, AZ (L.A.M.) · and Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red Oncología, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid (M.M.). · Pubmed 30110579
Genentech Inc.
2014
  • University of California Los Angeles, Los Angeles, California, USA; Analysis Group, Inc., Montreal, Quebec, Canada; Genentech Inc., South San Francisco, California, USA; Analysis Group, Inc., Boston, Massachusetts, USA. · University of California Los Angeles, Los Angeles, California, USA; Analysis Group, Inc., Montreal, Quebec, Canada; Genentech Inc., South San Francisco, California, USA; Analysis Group, Inc., Boston, Massachusetts, USA · Pubmed 25085897
15 Other Locations Show
Yearly article counts 4851191061400
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.